These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 6388496)

  • 1. The structure and mode of action of glycopeptide antibiotics of the vancomycin group.
    Barna JC; Williams DH
    Annu Rev Microbiol; 1984; 38():339-57. PubMed ID: 6388496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and study of antibacterial activities of antibacterial glycopeptide antibiotics conjugated with benzoxaboroles.
    Printsevskaya SS; Reznikova MI; Korolev AM; Lapa GB; Olsufyeva EN; Preobrazhenskaya MN; Plattner JJ; Zhang YK
    Future Med Chem; 2013 Apr; 5(6):641-52. PubMed ID: 23617428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the glycopeptide framework in the antibacterial activity of hydrophobic derivatives of glycopeptide antibiotics.
    Printsevskaya SS; Pavlov AY; Olsufyeva EN; Mirchink EP; Preobrazhenskaya MN
    J Med Chem; 2003 Mar; 46(7):1204-9. PubMed ID: 12646030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemistry and biology of glycopeptides with antibiotic activity.
    Tan H; Guo H; Wang S; Kong Q; Li W; Zeng W
    Protein Pept Lett; 2014; 21(10):1031-47. PubMed ID: 24975667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Glycopeptide antibiotics resistance mechanism as the basis for novel derivatives development capable to overcome resistance].
    Trenin AS; Olsuf'eva EN
    Bioorg Khim; 1997 Nov; 23(11):851-67. PubMed ID: 9518425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The structural biology of molecular recognition by vancomycin.
    Loll PJ; Axelsen PH
    Annu Rev Biophys Biomol Struct; 2000; 29():265-89. PubMed ID: 10940250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new series of glycopeptide antibiotics incorporating a squaric acid moiety. Synthesis, structural and antibacterial studies.
    Sztaricskai F; Batta G; Herczegh P; Balázs A; Jeko J; Roth E; Szabó PT; Kardos S; Rozgonyi F; Boda Z
    J Antibiot (Tokyo); 2006 Sep; 59(9):564-82. PubMed ID: 17136889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental study of the antibacterial activity and chemotherapeutic efficacy of the novel glycopeptide eremomycin].
    Malikova IV
    Antibiot Khimioter; 1989 Jan; 34(1):52-6. PubMed ID: 2543344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemical modification of glycopeptide antibiotics].
    Pavlov AIu; Preobrazhenskaia MN
    Bioorg Khim; 1998 Sep; 24(9):644-62. PubMed ID: 9813730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the positional attachment of glycopeptide/beta-lactam heterodimers.
    Long DD; Aggen JB; Chinn J; Choi SK; Christensen BG; Fatheree PR; Green D; Hegde SS; Judice JK; Kaniga K; Krause KM; Leadbetter M; Linsell MS; Marquess DG; Moran EJ; Nodwell MB; Pace JL; Trapp SG; Turner SD
    J Antibiot (Tokyo); 2008 Oct; 61(10):603-14. PubMed ID: 19168974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multivalent approach to drug discovery for novel antibiotics.
    Long DD; Aggen JB; Christensen BG; Judice JK; Hegde SS; Kaniga K; Krause KM; Linsell MS; Moran EJ; Pace JL
    J Antibiot (Tokyo); 2008 Oct; 61(10):595-602. PubMed ID: 19168973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the in vitro antibacterial activity of teicoplanin and vancomycin against gram-positive cocci.
    Ravizzola G; Pirali F; Foresti I; Turano A
    Drugs Exp Clin Res; 1987; 13(4):225-9. PubMed ID: 2957187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Design of Novel Carboxamides of Eremomycin and Vancomycin with 4- or 3-Amino Methyl Phenyl Boric Acid and Their Investigation].
    Bychkova EN; Korolev AM; Olsufyeva EN; Mirchink EP; Isakova EB
    Antibiot Khimioter; 2015; 60(9-10):7-11. PubMed ID: 27141632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Structure-activity relationships in a series of semisynthetic polycyclic glycopeptide antibiotics].
    Olsuf'eva EN; Preobrazhenskaia MN
    Bioorg Khim; 2006; 32(4):339-59. PubMed ID: 16909859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis of the activity of antibiotics of the vancomycin group.
    Williams DH; Waltho JP
    Biochem Pharmacol; 1988 Jan; 37(1):133-41. PubMed ID: 3276316
    [No Abstract]   [Full Text] [Related]  

  • 16. Multivalent antibiotics via metal complexes: potent divalent vancomycins against vancomycin-resistant enterococci.
    Xing B; Yu CW; Ho PL; Chow KH; Cheung T; Gu H; Cai Z; Xu B
    J Med Chem; 2003 Nov; 46(23):4904-9. PubMed ID: 14584941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vancomycin resistance: are there better glycopeptides coming?
    Linden PK
    Expert Rev Anti Infect Ther; 2008 Dec; 6(6):917-28. PubMed ID: 19053904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study of dimerization of polysynthetic derivatives of the antibiotic eremomycin by ESI MS and its role in elucidating antibacterial activity].
    Mirgorodskaia OA; Olsuf'eva EN; Kolume DE; Joergensen TJ; Roepstorff P; Pavlov AIu; Miroshnikova OV; Preobrazhenskaia MN
    Bioorg Khim; 2000 Aug; 26(8):631-40. PubMed ID: 11041003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure and mechanism of action of teicoplanin.
    Parenti F
    J Hosp Infect; 1986 Mar; 7 Suppl A():79-83. PubMed ID: 2871101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Non-natural aglycones of glycopeptide antibiotics of the vancomycin group. Synthesis and antibacterial activity].
    Pavlov AIu; Olsuf'eva EN; Miroshnikova OV; Reznikova MI; Lazhko EI; Malabarba A; Ciabatti R; Preobrazhenskaia MN
    Bioorg Khim; 1997 May; 23(5):410-21. PubMed ID: 9290051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.